Wisconsin biologics regulations.

Who may administer PRP, exosomes and stem cells in Wisconsin, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Wisconsin?

In Wisconsin, only licensed physicians (MD/DO) or advanced practitioners under a supervising physician can administer treatments.

Official sources

Wisconsin compliance guide.

FDA Compliance

The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular- and tissue-based products (HCT/Ps) to ensure patient safety. For clinics offering biologics in Wisconsin, understanding these regulations is critical. Key federal compliance points include:

  • Adhering to FDA’s guidelines on HCT/Ps to determine if your product is regulated solely under Section 361 of the Public Health Service Act.
  • Ensuring proper classification and registration if your product requires premarket approval or investigational new drug application (IND).
  • Following Good Tissue Practice (GTP) standards to maintain product quality, minimizing contamination risks.

Wisconsin State Regulations

In addition to federal FDA guidelines, providers in Wisconsin must adhere to state-specific regulations. Wisconsin’s Department of Health Services outlines health standards that apply to biologics, which may include laboratory certifications and restrictions on certain cellular therapies. Visit the Wisconsin Department of Health Services website for current guidelines on healthcare practices in the state.

Provider Qualifications

In Wisconsin, only licensed physicians (MD/DO) or advanced practitioners under a supervising physician can administer treatments. Providers should ensure they hold valid credentials under Wisconsin's licensing regulations and complete any necessary training in handling biologic products. For more details, check the Wisconsin Department of Safety and Professional Services for licensing requirements specific to your field.

Patient Informed Consent

Patient informed consent is crucial when administering biologics, as these treatments can involve risks and may have experimental aspects. Consent forms in Wisconsin should clearly outline:

  • Potential risks and benefits of the treatment
  • A statement indicating that certain therapies may be experimental
  • Alternative treatments available, if any
  • Any disclaimers regarding outcomes and lack of FDA approval for certain applications. Having a thorough consent process helps ensure patient understanding and compliance with Wisconsin's patient rights statutes.

Additional Compliance Considerations

Pre-Treatment and Post-Treatment Protocols

Develop protocols for pre-treatment screenings and post-treatment follow-ups to monitor patient outcomes. Adhering to these protocols supports patient safety and aligns with both FDA and Wisconsin’s best practices for medical procedures.

Standard Operating Procedures (SOPs)

Implement SOPs for all aspects of biologic handling, storage, and administration. These procedures ensure consistent quality and compliance with Good Manufacturing Practice (GMP) requirements.

Medical Liability Insurance

Ensure your clinic carries adequate medical liability insurance that covers biologic treatments. This coverage is essential for managing potential risks and liabilities associated with these therapies.

Marketing Compliance

All advertising and promotional materials must accurately represent the capabilities and limitations of biologic treatments. Avoid misleading language about unproven or experimental therapies, as non-compliant marketing can attract scrutiny from both FDA and Wisconsin regulatory authorities.

This guide is a general summary to help clinics understand compliance requirements for biologics in Wisconsin. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Wisconsin: common questions.

Who can administer stem cells, PRP and exosomes in Wisconsin?
In Wisconsin, only licensed physicians (MD/DO) or advanced practitioners under a supervising physician can administer treatments. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Wisconsin?
FDA rules are federal, so they apply in Wisconsin as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Wisconsin?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Wisconsin?
Start with the live webinar, then a discovery call and live training. After that we verify your Wisconsin licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Wisconsin? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.